Related Experiment Video
Updated: Jun 22, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Assessment factors for extrapolation from short-time to chronic exposure--are the REACH guidelines adequate?
Katarzyna Malkiewicz1, Sven Ove Hansson, Christina Rudén
1Royal Institute of Technology (KTH), Department of Philosophy and the History of Technology, Teknikringen 78B, 100 44 Stockholm, Sweden. Katarzyna.Malkiewicz@infra.kth.se
Abstract:
Due to the relative scarcity of long-term toxicity data, assessment factors for extrapolation from relatively short to chronic exposures have an important role in the risk assessment of chemicals. A recent REACH guidance document includes recommended default assessment factors that cover subacute-subchronic, subchronic-chronic, and subacute-chronic extrapolations. The recommended assessment factors are smaller than in most previous proposals, since they are calibrated to achieve central estimates (50th percentile of the target distribution) rather than a higher percentile such as the 95th, as has been more common. These assessment factors are nevertheless presented as representing a "widely agreed level of conservatism", a statement that may lead to misunderstandings of what is achieved by using them in a risk assessment. Assessment factors have been based on evidence from animal studies with different designs, in particular with focus on different endpoints. Our re-analysis of experimental data shows that using mortality as an endpoint leads to smaller assessment factors than if the factors are derived from corresponding ratios for non-lethal toxicity.
Related Concept Videos
Toxicity Testing in Animals
Dosage Regimens: Partial Pharmacokinetic Parameters
Assumptions of Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Bioavailability Study Design: Single Versus Multiple Dose Studies
